Published in J Neurochem on March 01, 1992
The protective role of D-glucose against 1-methyl-4-phenylpyridinium ion (MPP+): induced mitochondrial dysfunction in C6 astroglial cells. Neurochem Res (2010) 0.84
Variable toxicological response to the loss of OXPHOS through 1-methyl-4-phenylpyridinium-induced mitochondrial damage and anoxia in diverse neural immortal cell lines. Cell Biol Toxicol (2010) 0.81
Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. Life Sci (1985) 2.70
Actomyosin-like protein in brain. Science (1973) 2.55
The metabolism of rat brain mitochondria. Preparation and characterization. J Biol Chem (1970) 2.37
Control of citric acid cycle activity in rat heart mitochondria. J Biol Chem (1970) 2.28
In vivo inhibition of superoxide dismutase in mice by diethyldithiocarbamate. J Biol Chem (1976) 2.21
The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents. J Biol Chem (1974) 1.90
Transmission of serum hepatitis. JAMA (1970) 1.84
Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice. Science (1984) 1.72
Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors. Nature (1984) 1.62
Studies on the distinction between uptake inhibition and release of (3H)dopamine in rat brain tissue slices. Biochem Pharmacol (1975) 1.60
Cyclin-dependent kinases participate in death of neurons evoked by DNA-damaging agents. J Cell Biol (1998) 1.54
Transmission of serum hepatitis. 1970. JAMA (1996) 1.49
Alloxan-induced diabetes-evidence for hydroxyl radical as a cytotoxic intermediate. Biochem Pharmacol (1976) 1.46
Regeneration in the CNS: optimism mounts. Trends Neurosci (1998) 1.46
Induction of neuronal apoptosis by camptothecin, an inhibitor of DNA topoisomerase-I: evidence for cell cycle-independent toxicity. J Cell Biol (1996) 1.44
MPTP, MPP+ and mitochondrial function. Life Sci (1987) 1.35
Involvement of retinoblastoma family members and E2F/DP complexes in the death of neurons evoked by DNA damage. J Neurosci (2000) 1.33
G1/S cell cycle blockers and inhibitors of cyclin-dependent kinases suppress camptothecin-induced neuronal apoptosis. J Neurosci (1997) 1.31
Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity. Science (1989) 1.24
Studies on the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: inhibition of NAD-linked substrate oxidation by its metabolite, 1-methyl-4-phenylpyridinium. J Neurochem (1986) 1.21
Multiple pathways of neuronal death induced by DNA-damaging agents, NGF deprivation, and oxidative stress. J Neurosci (1998) 1.21
Correlation between the neostriatal content of the 1-methyl-4-phenylpyridinium species and dopaminergic neurotoxicity following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to several strains of mice. J Pharmacol Exp Ther (1991) 1.20
Destruction of sympathetic nerve terminals by 6-hydroxydopamine: protection by 1-phenyl-3-(2-thiazolyl)-2-thiourea, diethyldithiocarbamate, methimazole, cysteamine, ethanol and n-butanol. J Pharmacol Exp Ther (1976) 1.18
Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity. Neurosci Lett (1985) 1.18
Glutamate dehydrogenase deficiency in three patients with spinocerebellar syndrome. Ann Neurol (1980) 1.16
Metabolism of rat brain mitochondria. Studies on the potassium ion-stimulated oxidation of pyruvate. Biochem J (1971) 1.14
Compartmentation of glutamic acid metabolism in brain slices. J Neurochem (1968) 1.14
Comparing astrocytic cell lines that are inhibitory or permissive for axon growth: the major axon-inhibitory proteoglycan is NG2. J Neurosci (1999) 1.14
Amphetamine: evaluation of d- and l-isomers as releasing agents and uptake inhibitors for 3H-dopamine and 3H-norepinephrine in slices of rat neostriatum and cerebral cortex. J Pharmacol Exp Ther (1975) 1.10
An inhibitor of neurite outgrowth produced by astrocytes. J Cell Sci (1994) 1.09
The prevention of alloxan-induced diabetes in mice by dimethyl sulfoxide. Eur J Pharmacol (1977) 1.08
A sensitive assay for superoxide dismutase based on the autoxidation of 6-hydroxydopamine. Anal Biochem (1976) 1.07
6-Hydroxydopamine: evidence for superoxide radical as an oxidative intermediate. Science (1973) 1.07
Competitive and noncompetitive antagonists at N-methyl-D-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice. J Pharmacol Exp Ther (1991) 1.06
Characterization of cholesterol-free insect cells infectible by baculoviruses: effects of cholesterol on VSV fusion and infectivity and on cytotoxicity induced by influenza M2 protein. Exp Cell Res (1997) 1.06
Actomyosin-like protein in brain: subcellular distribution. J Neurochem (1972) 1.05
[A case of olfacto-genital dysplasia: study of the 34 published cases]. Ann Endocrinol (Paris) (1972) 1.05
Studies on the characterization of the inhibitory mechanism of 4'-alkylated 1-methyl-4-phenylpyridinium and phenylpyridine analogues in mitochondria and electron transport particles. J Neurochem (1994) 1.04
L-dopa cytotoxicity to PC12 cells in culture is via its autoxidation. J Neurochem (1995) 1.04
Mechanisms of astrocyte-directed neurite guidance. Cell Tissue Res (1997) 1.04
Structural dependence of the inhibition of mitochondrial respiration and of NADH oxidase by 1-methyl-4-phenylpyridinium (MPP+) analogs and their energized accumulation by mitochondria. Proc Natl Acad Sci U S A (1989) 1.03
Benzodiazepines and central inhibitory mechanisms. Naunyn Schmiedebergs Arch Pharmacol (1978) 1.03
Meige syndrome in the spectrum of Lewy body disease. Neurology (1994) 1.02
Compartmentation of citric acid cycle metabolism in brain: labelling of glutamate, glutamine, aspartate and gaba by several radioactive tracer metabolites. J Neurochem (1970) 1.01
The influence of dose and dosing interval on MPTP-induced dopaminergic neurotoxicity in mice. Eur J Pharmacol (1986) 1.01
The prevention of alloxan-induced diabetes by amygdalin. Life Sci (1980) 1.00
Role of hydroxyl radical scavengers dimethyl sulfoxide, alcohols and methional in the inhibition of prostaglandin biosynthesis. Prostaglandins (1976) 0.98
Tricarboxylic acid-cycle metabolism in brain. Effect of fluoroacetate and fluorocitrate on the labelling of glutamate, aspartate, glutamine and gamma-aminobutyrate. Biochem J (1970) 0.97
Potentiation by the tetraphenylboron anion of the effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its pyridinium metabolite. J Neurochem (1990) 0.96
Evidence that the loss of the voltage-dependent Mg2+ block at the N-methyl-D-aspartate receptor underlies receptor activation during inhibition of neuronal metabolism. J Neurochem (1992) 0.96
Tenascin-C contains domains that independently regulate neurite outgrowth and neurite guidance. J Neurosci (1999) 0.96
Characterization of the inhibitory mechanism of 1-methyl-4-phenylpyridinium and 4-phenylpyridine analogs in inner membrane preparations. J Biol Chem (1994) 0.96
Hydrogen peroxide production by rat brain in vivo. J Neurochem (1980) 0.95
Behavioral properties of GBR 12909, GBR 13069 and GBR 13098: specific inhibitors of dopamine uptake. Eur J Pharmacol (1984) 0.95
Dissection of astrocyte-mediated cues in neuronal guidance and process extension. Glia (1999) 0.95
Thermosensitive phenotype of transgenic mice overproducing human glutathione peroxidases. Proc Natl Acad Sci U S A (1995) 0.94
Decarboxylation studies of glutamate, glutamine, and aspartate from brain labelled with [1-14C]acetate, L-[U-14C]-aspartate, and L-[U-14C]glutamate. J Neurochem (1969) 0.94
Properties of cholesteryl esters in pure and mixed monolayers. J Lipid Res (1971) 0.94
Prevention of the nigrostriatal toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by inhibitors of 3,4-dihydroxyphenylethylamine transport. J Neurochem (1986) 0.93
An improved constant current source for micro-iontophoretic drug application studies. Electroencephalogr Clin Neurophysiol (1972) 0.93
Solution of fatty acids from monolayers spread at the air-water interface: identification of phase transformations and the estimation of surface charge. J Lipid Res (1970) 0.92
Excitatory amino acid neurotoxins: selectivity, specificity, and mechanisms of action. Based on an NRP one-day conference held June 30, 1980. Neurosci Res Program Bull (1981) 0.92
Responses of cultured cerebellar neurons to iontophoretically applied amino acids. Brain Res (1974) 0.90
[Clinical and biological study of an inhibitor of adrenocortical hormone synthesis: aminoglutethinide]. Ann Endocrinol (Paris) (1968) 0.90
Immortalized GABAergic cell lines derived from rat striatum using a temperature-sensitive allele of the SV40 large T antigen. Exp Neurol (1993) 0.89
Effects of cytochalasin B on uptake and release of putative transmitters by synaptosomes and on brain actomyosin-like protein. Nature (1974) 0.89
Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 2: Central administration of 1-methyl-4-phenylpyridinium. J Pharmacol Exp Ther (1994) 0.88
A truncated SV40 large T antigen lacking the p53 binding domain overcomes p53-induced growth arrest and immortalizes primary mesencephalic cells. Cell Tissue Res (1998) 0.88
An analysis of astrocytic cell lines with different abilities to promote axon growth. Brain Res (1995) 0.88
Characteristics of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the mouse. J Pharmacol Exp Ther (1987) 0.88
A distinct subset of tenascin/CS-6-PG-rich astrocytes restricts neuronal growth in vitro. J Neurosci (1995) 0.88
Interactions between neurons and glia in glutamate/glutamine compartmentation. Biochem Soc Trans (1987) 0.88
Relative vulnerability of dopamine and GABA neurons in mesencephalic culture to inhibition of succinate dehydrogenase by malonate and 3-nitropropionic acid and protection by NMDA receptor blockade. J Pharmacol Exp Ther (1995) 0.87
Chemosensitivity of medullary neurons in explant tissue cultures. Neuroscience (1991) 0.87
Glutamate metabolism in rat cortical astrocyte cultures. J Neurochem (1992) 0.87
Neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and methamphetamine in several strains of mice. Prog Neuropsychopharmacol Biol Psychiatry (1988) 0.86
Localization of beta-adrenergic receptors on differentiated cells of the central nervous system in culture. Proc Natl Acad Sci U S A (1987) 0.86
Long and short splice variants of human tenascin differentially regulate neurite outgrowth. Mol Cell Neurosci (1997) 0.86
Basic fibroblast growth factor regulates the ability of astrocytes to support hypothalamic neuronal survival in vitro. Dev Biol (1991) 0.86
Mitochondrial and metabolic toxicity of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine. J Pharmacol Exp Ther (1987) 0.86
Effect of vinblastine and colchicine on uptake and release of putative transmitters by synaptosomes and on brain actomyosin-like protein. J Neurochem (1973) 0.85
Inflammatory cytokines interact to modulate extracellular matrix and astrocytic support of neurite outgrowth. Exp Neurol (1997) 0.85
Protein kinase C mediates neurite guidance at an astrocyte boundary. Glia (2001) 0.85
Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 1: Systemic administration. J Pharmacol Exp Ther (1994) 0.85
Alterations of glial tumor cell Ca2+ metabolism and Ca2+-dependent cAMP accumulation by phorbol myristate acetate. J Biol Chem (1982) 0.84
Mechanisms underlying initiation of excitotoxicity associated with metabolic inhibition. J Pharmacol Exp Ther (1991) 0.84
Astrocyte topography and tenascin cytotactin expression: correlation with the ability to support neuritic outgrowth. Brain Res Dev Brain Res (1990) 0.84
4'-alkylated analogs of 1-methyl-4-phenylpyridinium ion are potent inhibitors of mitochondrial respiration. Biochem Biophys Res Commun (1990) 0.84
Chemically induced hypoglycemia and anoxia: relationship to glutamate receptor-mediated toxicity in retina. J Pharmacol Exp Ther (1990) 0.84
Oxidation of analogs of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by monoamine oxidases A and B and the inhibition of monoamine oxidases by the oxidation products. J Neurochem (1989) 0.84
Lactate prevents the alterations in tissue amino acids, decline in ATP, and cell damage due to aglycemia in retina. J Neurochem (2000) 0.84